Jeffrey Whiteaker

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Rachel Lundeen

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Qing Yu

Assistant Professor

University of Massachusetts Chan Medical School

UNITED STATES

View details

Talha Munir

UNITED KINGDOM

View details

Jade Moore

University of California, San Francisco

UNITED STATES

View details

Chia-Feng Tsai

Scorpion Therapeutics (United States)

UNITED STATES

View details

Christopher Paul Fox

Clinical Professor of Haematology

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeffrey Whiteaker

Research Interests

Explore related searches

Contact this professor

Articles (8)

Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry

Monitoring Both Extended and Tryptic Forms of Stable Isotope-Labeled Standard Peptides Provides an Internal Quality Control of Proteolytic Digestion in Targeted Mass Spectrometry-Based Assays

Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia

Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma

Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types

Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer

Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition

Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling

Collaborators (6)

Rachel Lundeen

Qing Yu

Talha Munir

Jade Moore

Chia-Feng Tsai

Christopher Paul Fox

Make your next move.